A story circulating online claims that a 17-year-old Canadian boy was at risk of serious illness and was being supported through end-of-life or hospice-type care when a treatment approach involving ivermectin and mebendazole allegedly helped him improve dramatically. The post frames this as a potentially unprecedented case: a teenager who, according to the narrative, avoided a worsening outcome associated with severe disease by receiving the two medicines.
The account emphasizes the boy’s age and Canadian context, presenting him as the central figure in what the author describes as “breaking news.” The wording suggests that the teen had been placed under hospice care because clinicians believed his condition was extremely serious or not expected to improve. Against that backdrop, the story asserts that administering ivermectin and mebendazole was a turning point. It also portrays the teen’s recovery as rapid and remarkable, using celebratory language to highlight a dramatic shift from decline to improvement.
Beyond the medical claims, the narrative includes a strong conflict element. It alleges that Canadian doctors and politicians are trying to stop the treatment or undermine the boy’s care. The text portrays this as a confrontation between the family’s chosen course of action and institutional decision-making. The author’s phrasing implies that there is resistance within mainstream medical or governmental circles, and that the boy’s ongoing improvement is occurring despite that opposition.
The story’s tone is highly promotional and urgent, repeatedly stressing that the case may be the “world’s first” of its kind—specifically, a child or teen reportedly saved from hospice care through the use of those particular drugs. The text also frames the teen’s recovery as evidence supporting the treatment approach, suggesting the outcome itself serves as a validation of the medicines used.
However, the provided input contains no verifiable clinical details, such as the boy’s diagnosis, objective medical measurements, dates of treatment, dosing information, hospital or physician names, or independent confirmation of the claimed improvement. It also does not provide documentation of the underlying medical rationale for the medicines in this specific case, nor does it outline what doctors or officials said in response. As a result, the story reads as an advocacy-style account rather than a fully substantiated news report.
Even so, the core narrative is clear: an online claimant says a 17-year-old Canadian teen who was reportedly in hospice care began improving after ivermectin and mebendazole were used, and the author attributes this to the medicines. The post further claims that doctors and politicians are attempting to interfere with the situation, implying a broader controversy around the acceptance and use of these medicines in that context.
The inclusion of emotionally charged language—such as references to “saving” the child, “breaking news,” and the implied efforts to “kill him” through opposition—indicates the author’s perspective and intent to persuade. The story also suggests the boy’s improvement is ongoing and that the case is being closely watched, particularly as it challenges typical expectations associated with hospice-type care.
Overall, the narrative centers on a dramatic medical turnaround attributed to ivermectin and mebendazole for a 17-year-old Canadian teen who was allegedly facing a dire prognosis. It presents the situation as exceptional and possibly unprecedented, while also depicting institutional resistance from healthcare providers and political figures. The lack of concrete supporting evidence in the supplied text means that readers should treat the claims as allegations made by the post rather than confirmed findings.
Source: Source
William Makis: BREAKING NEWS: 17 year old Canadian boy saved from Children’s HOSPICE by Ivermectin and Mebendazole! Canadian doctors and politicians are trying to kill him but he’s improving dramatically! 💪 This may be a world’s first!! A child saved from HOSPICE 🙏 STORY: 17 year old. #breaking
— @MakisMedicine May 1, 2026
News Source
SHOP AMAZON BEST SELLERS, CLICK TO BUY FROM AMAZON.
